MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ymthe.2025.01.007

Медицинская библиотека · Molecular therapy : the journal of the American Society of Gene Therapy · 2025

Effect of immunoadsorption on clinical presentation and immune alterations in COVID-19-induced and/or aggravated ME/CFS.

Anft Moritz, Wiemers Lea, Rosiewicz Kamil S, Doevelaar Adrian, Skrzypczyk Sarah, Kurek Julia, Kaliszczyk Sviatlana, Seidel Maximilian, Stervbo Ulrik, Seibert Felix S, Westhoff Timm H, Babel Nina

СтатьяНаблюдательное исследованиеПеревод в очереди

Аннотация

Autoantibodies (AABs) are currently being investigated as causative or aggravating factors during post-COVID. In this study, we analyze the effect of immunoadsorption therapy on symptom improvement and the relationship with immunological parameters in post-COVID patients exhibiting symptoms of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) induced or aggravated by an SARS-CoV-2 infection. This observational study includes 12 post-COVID patients exhibiting a predominance of ME/CFS symptoms alongside increased concentrations of autonomic nervous system receptor (ANSR) autoantibodies and neurological impairments. We found that following immunoadsorption therapy, the ANSR AABs were nearly eliminated from the patients' blood. The removal of immunoglobulin G antibodies was accompanied by a decrease of pro-inflammatory cytokines including interleukin (IL)-4, IL-2, IL-1β, tumor necrosis factor, and IL-17A serum levels, and a significant reduction of soluble spike protein. Notably, a strong positive correlation between pro-inflammatory cytokines and ASNR-AABs β1, β2, M3, and M4 was observed in spike protein-positive patients, whereas no such correlation was evident in spike protein-negative patients. Thirty days post-immunoadsorption therapy, patients exhibited notable improvement in neuropsychological function and a modest but statistically significant amelioration of hand grip strength was observed. However, neither self-reported symptoms nor scores on ME/CFS questionnaires showed a significant improvement and a rebound of the removed proteins occurring within a month.

Для цитирования: Anft Moritz, Wiemers Lea, Rosiewicz Kamil S, Doevelaar Adrian, Skrzypczyk Sarah, Kurek Julia, Kaliszczyk Sviatlana, Seidel Maximilian, Stervbo Ulrik, Seibert Felix S, Westhoff Timm H, Babel Nina. Effect of immunoadsorption on clinical presentation and immune alterations in COVID-19-induced and/or aggravated ME/CFS.. Molecular therapy : the journal of the American Society of Gene Therapy. 2025. DOI: 10.1016/j.ymthe.2025.01.007.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.